874
ULTRA-DEEP PACBIO SEQUENCING REVEALS THE FEATURES AND GENOMIC FUNCTION OF GUT VIRUSES IN COLORECTAL CANCER BASED ON 23992 VIRUS GENOMES
Date
May 20, 2024
Tracks
Related Products
<i>LACTOCOCCUS LACTIS </i>SUPPRESSES COLORECTAL TUMORIGENESIS BY RESTORING GUT MICROBIOME COMPOSITION AND GENERATING BENEFICIAL ALPHA- MANNOSIDASE
BACKGROUND: Through shotgun metagenomic sequencing, we identified the depletion of probiotic species_ Lactobacillus acidophilus_ in stools of mice with non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLD-HCC)…
ENTEROTOXIGENIC<i> BACTEROIDES FRAGILIS</i> PROMOTES CHEMORESISTANCE AND TARGETING <i>BACTEROIDES FRAGILIS</i> BY PHAGE <i>AV7</i> RESTORES CHEMOSENSITIVITY IN COLORECTAL CANCER
BACKGROUND AND AIMS: Chemoresistance is a major cause of colorectal cancer (CRC) recurrence and death. The critical role of gut microbiome in the efficacy of CRC chemotherapy remains unclear…
<i>CARNOBACTERIUM MALTAROMATICUM</i> ENHANCES INTESTINAL VITAMIN D PRODUCTION TO SUPPRESS FEMALE COLORECTAL CANCER
BACKGROUND: Through shotgun metagenomic sequencing, we identified the depletion of probiotic species_ Lactobacillus acidophilus_ in stools of mice with non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLD-HCC)…
THE EFFECT OF GUT MICROBIOTA ON IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF PAN-CANCER AND NOVEL MICROBIAL BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSE
The gut microbiota is closely related to cancer patient response to immune checkpoint inhibitors (ICI). However, there are inconsistencies in species affecting ICI efficacy, whilst the role of non-bacterial microbes in immunotherapy remains elusive…